Vedolizumab-4020: A Multicenter, Single-arm, Open-label, Phase 4 Study to Evaluate the Safety and Efficacy of Vedolizumab in Indian Patients With Ulcerative Colitis and Crohn’s Disease First published 10/09/2018 Last updated 22/01/2025 EU PAS number:EUPAS23702 Study Finalised